Bisodol Antacid Chewable TabletsCalcium Carbonate 522mgMagnesium Carbonate Light 68mgSodium Hydrogen Carbonate 64mg

Land: Irland

Sprache: Englisch

Quelle: HPRA (Health Products Regulatory Authority)

Wirkstoff:

Calcium carbonate; Sodium hydrogen carbonate; Light magnesium carbonate

Verfügbar ab:

Teva B.V.

ATC-Code:

A02AC; A02AC01

INN (Internationale Bezeichnung):

Calcium carbonate; Sodium hydrogen carbonate; Light magnesium carbonate

Dosierung:

522/68/64 milligram(s)

Darreichungsform:

Chewable tablet

Verschreibungstyp:

Product not subject to medical prescription

Therapiebereich:

Calcium compounds; calcium carbonate

Berechtigungsstatus:

Marketed

Berechtigungsdatum:

1983-04-01

Gebrauchsinformation

PACKAGE LEAFLET: INFORMATION FOR THE USER
BISODOL® ANTACID CHEWABLE TABLETS
Calcium Carbonate 522 mg, Magnesium Carbonate, Light 68 mg, Sodium
Hydrogen Carbonate 64
mg.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE, BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
This medicine is available without prescription. However, you still
need to take Bisodol Antacid
Chewable Tablets carefully to get the best results.
• Always use this medicine exactly as your doctor or pharmacist has
told you.
• Keep this leaflet. You may need to read it again.
• Ask your pharmacist if you need more information or advice.
• If you get any side effects, talk to your doctor, pharmacist or
nurse. This includes any possible side
effects not listed in this leaflet. See section 4.
• You must contact a doctor if your signs of illness worsen or do
not improve.
WHAT IS IN THIS LEAFLET:
1. What Bisodol Antacid Chewable Tablets are and what they are used
for
2. What you need to know before you take Bisodol Antacid Chewable
Tablets
3. How to take Bisodol Antacid Chewable Tablets
4. Possible side effects
5. How to store Bisodol Antacid Chewable Tablets
6. Contents of the pack and other information
1. WHAT BISODOL ANTACID CHEWABLE TABLETS ARE AND WHAT THEY ARE USED
FOR
Bisodol Antacid Chewable Tablets are chewable tablets. They work by
neutralising excess stomach
acid.
Bisodol Antacid Chewable Tablets treat the pain and discomfort of acid
indigestion, heartburn and
trapped wind.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE BISODOL ANTACID CHEWABLE
TABLETS
DO NOT TAKE BISODOL ANTACID CHEWABLE TABLETS:
• If you are allergic to any of the ingredients of this medicine
(listed in section 6).
• If you have been told the level of phosphate in your blood is low
(hypophosphataemia).
• If you have kidney problems.
• If you have been told the level of calcium in your blood is high
(hypercalcaemia) or the level of
calcium in your urine is high (hypercalciuria).
WARNINGS AND PRECAUTIONS
TALK TO YOUR DOCTOR OR PHARMACIST

Fachinformation

Health Products Regulatory Authority
04 April 2022
CRN00CVP6
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Bisodol Antacid Chewable TabletsCalcium Carbonate 522mgMagnesium
Carbonate Light 68mgSodium Hydrogen Carbonate
64mg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each chewable tablet contains:
64 mg of Sodium Hydrogen Carbonate
522 mg of Calcium Carbonate
68 mg of Magnesium Carbonate, Light
Excipients with known effect:
Each chewable tablet also contains 538.3mg of sucrose
Each chewable tablets also contains 18mg of sodium
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Chewable Tablet
Circular, smooth white bevel-edged tablet marked Bisodol on both
sides.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
In the relief of symptoms of indigestion, dyspepsia, heartburn,
acidity and flatulence.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults_
Two tablets as required.
_Paediatric population_
Children under 12 years: not recommended
Do not take more than 12 tablets in 24 hours.
Method of administration
Bisodol Chewable Tablets are to be administered orally
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substances or to any of the excipients
listed in section 6.1.
Hypophosphataemia. Avoid in patients with renal failure.
Hypercalcaemia and hypercalciuria.
Health Products Regulatory Authority
04 April 2022
CRN00CVP6
Page 2 of 4
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE

Magnesium salts may cause central nervous depression in the presence
of renal insufficiency.

Persons with kidney disease or receiving medical treatment should
consult their doctor before using.

Prolonged use should be avoided. If the symptoms persist, medical
advice should be sought.

Do not exceed the stated dose except on medical advice.

Ingestion of large amounts of antacid tablets may cause milk-alkali
syndrome.

Bisodol contains sucrose: Patients with rare hereditary problems of
fructose intolerance,
glucose-galactose malabsorption or sucrase-isomaltase